RxDoctor Payments Data

Jazba Soomro, MD

Neurology · Houston, TXNPI 1841555760

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,979 of the $6,316 with a category attached, or 78.8%. Medtronic accounts for 80.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $4,632 and has fallen 98.0% since, to $93 in 2025.

$6,316in general payments, 2019–2025

Across 31 payments — averaging $203.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Penumbra, Inc.$596
  • Stryker$206
  • Imperative Care, Inc$155
  • Microvention, Inc.$60
  • Qapel Medical Inc$54
  • plus $181 from 5 others
$55,586in research payments, 2019–2025

Across 7 payments — averaging $7940.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • MIVI Neuroscience, Inc.$56K

What the payments were for

  • Travel & lodging$4,97979%
  • Food & beverage$1,33721%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,316 in reported general payments places this provider in the 65th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas →

Medicare billing

Part B allowed, 2024
$33,672
Medicare patients
42
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →